Sept 26 (Reuters) - The European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer's ...

Stock falls. Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. We recently compiled a list of the 8 Best Wide ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...

NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...

In a report released today, Akash Tewari from Jefferies assigned a Buy rating to Pfizer (PFE – Research Report), with a price target of $35.00. The company’s shares closed yesterday at $30.07.

Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme disease vaccine, but that hasn’t stopped the companies collecting more ...

Journalist Alex Berenson said Meta CEO Mark Zuckerberg’s admission that his company, Facebook, was pressured by the Biden-Harris administration to censor Americans, particularly regarding COVID ...

Aug. 31 (UPI) --A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that are now circulating. The U.S. Food and Drug ...

Pfizer Inc. (PFE) said Saturday that its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna ... and syringes with the ... [+] logo of US biotech company Novavax.

Through its Ignite program, Pfizer partners with biotechs to help them advance new drugs from preclinical development all the way to market.Ignite mainly focuses on oncology, inflammation and ...

Pfizer is a global pharmaceutical giant with an impressive portfolio of over 350 marketed medicines, 113 experimental candidates in clinical trials, and a presence in more than 200 countries.